Abstract
Many nanoscale biomaterials fail to reach the clinical trial stage due to a poor understanding of the fundamental principles of their in vivo behaviour. Here we describe the transport, transformation and bioavailability of MoS2 nanomaterials through a combination of in vivo experiments and molecular dynamics simulations. We show that after intravenous injection molybdenum is significantly enriched in liver sinusoid and splenic red pulp. This biodistribution is mediated by protein coronas that spontaneously form in the blood, principally with apolipoprotein E. The biotransformation of MoS2 leads to incorporation of molybdenum into molybdenum enzymes, which increases their specific activities in the liver, affecting its metabolism. Our findings reveal that nanomaterials undergo a protein corona-bridged transport–transformation–bioavailability chain in vivo, and suggest that nanomaterials consisting of essential trace elements may be converted into active biological molecules that organisms can exploit. Our results also indicate that the long-term biotransformation of nanomaterials may have an impact on liver metabolism.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The data supporting the findings of this study are available from the corresponding author upon reasonable request. The protein identification was conducted using UniProtKB Mus musculus sequence database (Swiss-Prot (560,459), UniProt release 2019_06, https://www.uniprot.org/). The protein classification and gene ontology were identified by Gene Ontology (molecular function and biological process) (http://geneontology.org/, 7 January 2019 release). Source data are provided with this paper.
Code availability
The original analysis code for molecular dynamics simulation is kept at the CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety at the Institute of High Energy Physics and is available from the corresponding authors upon reasonable request.
References
Manzeli, S., Ovchinnikov, D., Pasquier, D., Yazyev, O. V. & Kis, A. 2D transition metal dichalcogenides. Nat. Rev. Mater. 2, 17033 (2017).
Yadav, V., Roy, S., Singh, P., Khan, Z. & Jaiswal, A. 2D MoS2‐based nanomaterials for therapeutic, bioimaging, and biosensing applications. Small 15, 1803706 (2019).
Chen, Y., Tan, C., Zhang, H. & Wang, L. Two-dimensional graphene analogues for biomedical applications. Chem. Soc. Rev. 44, 2681–2701 (2015).
Li, B. L. et al. Directing assembly and disassembly of 2D MoS2 nanosheets with DNA for drug delivery. ACS Appl. Mater. Interfaces 9, 15286–15296 (2017).
Liu, T. et al. Drug delivery with pegylated MoS2 nano‐sheets for combined photothermal and chemotherapy of cancer. Adv. Mater. 26, 3433–3440 (2014).
Yin, W. et al. High-throughput synthesis of single-layer MoS2 nanosheets as a near-infrared photothermal-triggered drug delivery for effective cancer therapy. ACS Nano 8, 6922–6933 (2014).
Cheng, L. et al. Pegylated WS2 nanosheets as a multifunctional theranostic agent for in vivo dual-modal CT/photoacoustic imaging guided photothermal therapy. Adv. Mater. 26, 1886–1893 (2014).
Xi, Q. et al. Highly sensitive and selective strategy for microRNA detection based on WS2 nanosheet mediated fluorescence quenching and duplex-specific nuclease signal amplification. Anal. Chem. 86, 1361–1365 (2014).
Sarkar, D. et al. MoS2 field-effect transistor for next-generation label-free biosensors. ACS Nano 8, 3992–4003 (2014).
Wang, Z. et al. Chemical dissolution pathways of MoS2 nanosheets in biological and environmental media. Environ. Sci. Technol. 50, 7208–7217 (2016).
Kurapati, R. et al. Enzymatic biodegradability of pristine and functionalized transition metal dichalcogenide MoS2 nanosheets. Adv. Funct. Mater. 27, 1605176 (2017).
Hao, J. et al. In vivo long-term biodistribution, excretion, and toxicology of PEGylated transition-metal dichalcogenides MS2 (M = Mo, W, Ti) nanosheets. Adv. Sci. 4, 1600160 (2017).
Schwarz, G., Mendel, R. R. & Ribbe, M. W. Molybdenum cofactors, enzymes and pathways. Nature 460, 839 (2009).
Tenzer, S. et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotech. 8, 772–781 (2013).
Boukhicha, M., Calandra, M., Measson, M.-A., Lancry, O. & Shukla, A. Anharmonic phonons in few-layer MoS2: Raman spectroscopy of ultralow energy compression and shear modes. Phys. Rev. B 87, 195316 (2013).
Pertoft, H. Fractionation of cells and subcellular particles with Percoll. J. Biochem. Biophy. Meth. 44, 1–30 (2000).
Anderson, D. C., Mace, M. L., Brinkley, B. R., Martin, R. R. & Smith, C. W. Recurrent infection in glycogenosis type Ib: abnormal neutrophil motility related to impaired redistribution of adhesion sites. J. Infect. Dis. 143, 447–459 (1981).
Almeida, M. C. D., Silva, A. C., Barral, A. & Barral Netto, M. A simple method for human peripheral blood monocyte isolation. Mem. Inst. Oswaldo Cruz 95, 221–223 (2000).
Parker, L. C., Whyte, M. K. B., Dower, S. K. & Sabroe, I. The expression and roles of Toll-like receptors in the biology of the human neutrophil. J. Leukoc. Biol. 77, 886–892 (2005).
Lunov, O. et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 5, 1657–1669 (2011).
Monopoli, M. P., Åberg, C., Salvati, A. & Dawson, K. A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotech. 7, 779–786 (2012).
Yang, S. T., Liu, Y., Wang, Y. W. & Cao, A. Biosafety and bioapplication of nanomaterials by designing protein–nanoparticle interactions. Small 9, 1635–1653 (2013).
Schoettler, S. et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat. Nanotech. 11, 372–377 (2016).
Bertrand, N. et al. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics. Nat. Commun. 8, 777 (2017).
Cai, R. & Chen, C. The crown and the scepter: roles of the protein corona in nanomedicine. Adv. Mater. 1805740, 1–13 (2018).
Floyd, C. N. & Ferro, A. The platelet fibrinogen receptor: from megakaryocyte to the mortuary. J. R. Soc. Med. Cardiovasc. Dis. 1, 1–13 (2012).
Murao, K. et al. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J. Biol. Chem. 272, 17551–17557 (1997).
Shibuya, A. et al. Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 1, 441–446 (2000).
Ross, G. D. & Lambris, J. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes. J. Exp. Med. 155, 96–110 (1982).
Qu, Y. et al. Full assessment of fate and physiological behavior of quantum dots utilizing Caenorhabditis elegans as a model organism. Nano Lett. 11, 3174–3183 (2011).
Gouaux, E. & MacKinnon, R. Principles of selective ion transport in channels and pumps. Science 310, 1461–1465 (2005).
Cai, R. et al. Corona of thorns: the surface chemistry-mediated protein corona perturbs the recognition and immune response of macrophages. ACS Appl. Mater. Interfaces 12, 1997–2008 (2020).
Monteiro, R. C., Kubagawa, H. & Cooper, M. Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans. J. Exp. Med. 171, 597–613 (1990).
Suits, A. G., Chait, A., Aviram, M. & Heinecke, J. W. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. Proc. Natl Acad. Sci. USA 86, 2713–2717 (1989).
Chen, C., Li, Y.-F., Qu, Y., Chai, Z. & Zhao, Y. Advanced nuclear analytical and related techniques for the growing challenges in nanotoxicology. Chem. Soc. Rev. 42, 8266–8303 (2013).
Wang, L. et al. Use of synchrotron radiation-analytical techniques to reveal chemical origin of silver-nanoparticle cytotoxicity. ACS Nano 9, 6532–6547 (2015).
Hille, R. Molybdenum and tungsten in biology. Trends Biochem. Sci. 27, 360–367 (2002).
Hille, R., Nishino, T. & Bittner, F. Molybdenum enzymes in higher organisms. Coord. Chem. Rev. 255, 1179–1205 (2011).
Swinney, R., Hsu, S. & Tomlinson, G. Phase I and phase II enzyme polymorphisms and childhood cancer. J. Investig. Med. 54, 303–320 (2006).
Sweeney, B. P. & Bromilow, J. Liver enzyme induction and inhibition: implications for anaesthesia. Anaesthesia 61, 159–177 (2006).
Mota, C. et al. Critical overview on the structure and metabolism of human aldehyde oxidase and its role in pharmacokinetics. Coord. Chem. Rev. 368, 35–59 (2018).
Li, H., Cui, H., Kundu, T. K., Alzawahra, W. & Zweier, J. L. Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase. J. Biol. Chem. 283, 17855–17863 (2008).
Hille, R., Hall, J. & Basu, P. The mononuclear molybdenum enzymes. Chem. Rev. 114, 3963–4038 (2014).
Cao, M., Li, J., Tang, J., Chen, C. & Zhao, Y. Gold nanomaterials in consumer cosmetics nanoproducts: analyses, characterization, and dermal safety assessment. Small 12, 5488–5496 (2016).
Ren, J. et al. Precision nanomedicine development based on specific opsonization of human cancer patient-personalized protein coronas. Nano Lett. 19, 4692–4701 (2019).
Elci, S. G. et al. Surface charge controls the suborgan biodistributions of gold nanoparticles. ACS Nano 10, 5536–5542 (2016).
Apenova, N., Peng, H., Hecker, M. & Brinkmann, M. A rapid and sensitive fluorometric method for determination of aldehyde oxidase activity. Toxicol. Appl. Pharm. 341, 30–37 (2018).
Kollman, J. M., Pandi, L., Sawaya, M. R., Riley, M. & Doolittle, R. F. Crystal structure of human fibrinogen. Biochemistry 48, 3877–3886 (2009).
Sugio, S., Kashima, A., Mochizuki, S., Noda, M. & Kobayashi, K. Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng. 12, 439–446 (1999).
Hatters, D. M., Peters-Libeu, C. A. & Weisgraber, K. H. Engineering conformational destabilization into mouse apolipoprotein E. A model for a unique property of human apolipoprotein E4. J. Biol. Chem. 280, 26477–26482 (2005).
Nagar, B., Jones, R. G., Diefenbach, R. J., Isenman, D. E. & Rini, J. M. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 280, 1277–1281 (1998).
Li, Y. X. et al. Structural insights into immunoglobulin M. Science 367, 1014–1017 (2020).
Acknowledgements
This work was supported by the National Key Research and Development Program of China (2016YFA0201600, 2020YFA0710700 and 2016YFE0133100), the Innovative Research Groups of the National Natural Science Foundation of China (11621505), the National Natural Science Foundation of China (31971311, 2202780088), the Program for International S&T Cooperation Projects of the Ministry of Science and Technology of China (2018YFE0117200), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB36000000), the CAS Interdisciplinary Innovation Team, the Bureau of International Cooperation Chinese Academy of Sciences (GJHG1852), the Research and Development Project in Key Areas of Guangdong Province (2019B090917011) and the Users with Excellence Project of Hefei Science Center CAS (2018HSC-UE004). We greatly appreciate the support from beamlines BL-15U1A and BL-14W1 (SSRF), beamlines 1W1B and 4B7A (BSRF) and beamline BL07W at the Hefei Light Source of the National Synchrotron Radiation Laboratory.
Author information
Authors and Affiliations
Contributions
C.C. conceived the project and supervised the study. C.C., M.C. and R.C. designed the experiments. M.C. conducted the experiments with assistance from M.G., L.W., C.X., Y.W., Y.L. and S.X. L.Z., H.Y. and X.W. performed molecular dynamics simulation. Intravital confocal fluorescence microscopy imaging was conducted with help from Y.W. L.Z, L.W. and Y.W. assisted with collecting data of synchrotron radiation microbeam X-ray fluorescence imaging and X-ray absorption near-edge spectra. Y.G., Y.C., Y.W. and X.T. helped to collect and analyse the X-ray nano-CT imaging results. M.C., R.C., L.Z. and C.C. analysed results and wrote the manuscript. C.C. and Y.Z. edited the manuscript. All authors approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Peer review information Nature Nanotechnology thanks the anonymous reviewers for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Proteomic analysis of the protein corona (PC) and gene ontology classification.
a, Other components detected in protein corona. b, Relative abundance of proteins recognized by mononuclear phagocytic cells in the protein corona. Gene ontology analysis of the protein corona, molecular function (c) and biological process (d).
Extended Data Fig. 2 The molecular dynamics (MD) simulations to analyse the interactions between the MoS2 nanodots and fibrinogen (Fg), albumin (HSA) and apolipoprotein E (ApoE).
Root mean square deviation (RMSD, a), Salt-bridge (b) and H-bond (c) analysis in MD simulation of the interactions between 2H, 1 T MoS2 and fibrinogen (Fg), albumin (HSA) and apolipoprotein E (ApoE).
Extended Data Fig. 3 The biodistribution of MoS2@HSA nanocomplexes.
a, SRXRF imaging of Mo, S, Fe, K, Ca in liver at dose of 5.0 mg/kg (in terms of MoS2) at 6 h, 3 d, 14 d post-injection. SRXRF imaging of K, Ca in liver (b) and spleen (c) at dose of 5.0 mg/kg (in terms of MoS2) at 1 d, 7 d, 60 d post-injection. SRXRF images are representative of three independent experiments. d, The amounts of Mo in skin, muscle, bone, intestine, stomach and brain at the indicated time points after intravenous injection at the dose of 5.0 mg/kg. The data are presented as the mean ± S.D. n = 3 biologically independent mice. Scale bar: 1 mm.
Extended Data Fig. 4 Degradation and bioavailability of MoS2@HSA-derived Mo in the liver after treatment with dose of 0.25 mg/kg (MoS2 concentration).
a, Mo K-edge XANES (solid lines) and fitted curves (dashed lines) of liver preparations from mice treated with MoS2@HSA (0.25 mg MoS2/kg). b, Increased activity of molybdenum enzymes (AOX: Aldehyde oxidase; XOR: Xanthine oxidoreductase) in the liver of mice intravenously injected with MoS2 nanocomplex at a dose of 0.25 mg MoS2/kg (n = 3 biologically independent mice). c, Chemical forms and ratio of Mo in liver of mice treated with 0.25 mg MoS2/kg body weight fitted from the XANES spectra. n = 3 biologically independent experiments. The data are shown as the mean ± S.D. Statistical significance was tested with a two-tailed, unpaired Student’s t-test. *p < 0.05, **p < 0.01, ***p < 0.001.
Extended Data Fig. 5 Degradability of MoS2@HSA in the spleen after treatment with dose of 5.0 mg/kg (MoS2 concentration).
a, Mo K-edge XANES (solid lines) and fitted curves (dash lines) of spleens from mice treated at the indicated times with MoS2 nanocomplex. b, Mo chemical forms and ratios in the samples were calculated based on the Mo K-edge XANES. The Data are shown as the mean ± S.D. c, Chemical forms and ratios of Mo in spleen of mice treated with 5.0 mg MoS2/kg body weight were fitted from the XANES spectra. n = 3 biologically independent experiments. Data are shown as mean ± S.D.
Extended Data Fig. 6 HSA and blood proteins retard the oxidation of MoS2 nanodots.
a, Mo K-edge XANES of bare MoS2, MoS2 coated with HSA and mouse blood proteins before and after incubation in PBS for 30 d at 37 °C with the presence of air. b, Mo chemical forms and ratios in the indicated samples were calculated based on the measurements of Mo K-edge XANES. Mo L3-edge and S K-edge XANES of reference materials with different valence states of Mo (c) and S (d), bare MoS2 and MoS2@HSA incubated in PBS at 37 °C with the presence of air for 6 h (e, f). 2D MoS2 nanodots incubated with H2O2 were set as positive control.
Supplementary information
Supplementary Information
Supplementary Figs. 1–11, Table 1, methods and refs. 1–12.
Supplementary Video 1
Intravital microscopy imaging of blood vessel.
Supplementary Video 2-1
3D nano-CT imaging of MoS2-treated neutrophil.
Supplementary Video 2-2
3D nano-CT imaging of MoS2-treated PBMCs.
Supplementary Video 2-3
3D nano-CT imaging of MoS2-treated platelets.
Supplementary Video 2-4
3D nano-CT imaging of control neutrophils.
Supplementary Video 2-5
3D nano-CT imaging of control PBMCs.
Supplementary Video 2-6
3D nano-CT imaging of control platelets.
Supplementary Video 3-1
Molecular dynamics trajectory of apolipoprotein E with 1T MoS2 nanodots.
Supplementary Video 3-2
Molecular dynamics trajectory of apolipoprotein E with 2H MoS2 nanodots.
Supplementary Video 3-3
Molecular dynamics trajectory of fibrinogen with 1T MoS2 nanodots.
Supplementary Video 3-4
Molecular dynamics trajectory of fibrinogen with 2H MoS2 nanodots.
Supplementary Video 3-5
Molecular dynamics trajectory of albumin with 1T MoS2 nanodots.
Supplementary Video 3-6
Molecular dynamics trajectory of albumin with 2H MoS2 nanodots.
Source data
Source Data Fig. 1
Numerical Source Data.
Source Data Fig. 2
Numerical Source Data.
Source Data Fig. 3
Numerical Source Data.
Source Data Fig. 4
Numerical Source Data.
Source Data Fig. 5
Numerical Source Data.
Source Data Extended Data Fig. 1
Numerical Source Data.
Source Data Extended Data Fig. 2
Numerical Source Data.
Source Data Extended Data Fig. 3
Numerical Source Data.
Source Data Extended Data Fig. 4
Numerical Source Data.
Source Data Extended Data Fig. 5
Numerical Source Data.
Source Data Extended Data Fig. 6
Numerical Source Data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cao, M., Cai, R., Zhao, L. et al. Molybdenum derived from nanomaterials incorporates into molybdenum enzymes and affects their activities in vivo. Nat. Nanotechnol. 16, 708–716 (2021). https://doi.org/10.1038/s41565-021-00856-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-021-00856-w
This article is cited by
-
Two-dimensional nanomaterials induced nano-bio interfacial effects and biomedical applications in cancer treatment
Journal of Nanobiotechnology (2024)
-
In situ label-free X-ray imaging for visualizing the localization of nanomedicines and subcellular architecture in intact single cells
Nature Protocols (2024)
-
Molecular Mechanisms of Intracellular Delivery of Nanoparticles Monitored by an Enzyme-Induced Proximity Labeling
Nano-Micro Letters (2024)
-
Regulation of biological processes by intrinsically chiral engineered materials
Nature Reviews Materials (2023)
-
Inside-out assembly of viral antigens for the enhanced vaccination
Signal Transduction and Targeted Therapy (2023)